Interdependence of gene expression for early steps of cephalosporin synthesis in Streptomyces clavuligerus.
The early steps of cephamycin synthesis by S. clavuligerus are catalyzed sequentially by lysine epsilon-aminotransferase (LAT), delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase (ACVS) and isopenicillin N synthase (cyclase, IPNS). The genes (lat, pcbAB, and pcbC, respectively) are closely linked in the same order as the enzymes act in the biosynthetic pathway and are transcribed in the same direction. Four cephamycin non- (or low-) producing mutants are pleiotropic in that they have undetectable or markedly diminished levels of ACVS and cyclase; two mutants almost completely lack LAT activity. All four mutants are complemented in cephamycin formation by transformation with pNBR1, a plasmid containing a 7.2-kb genomic region of S. clavuligerus in vector pIJ702. The cloned DNA was found to possess no part of the cyclase gene, but instead it contained lat and the 5' upstream part of pcbAB. Doran et al. reported that the 31-bp region between pcbAB and pcbC contains no recognizable promoter or transcription termination sequences. We found that there are 153 bp between the lat ORF and the pcbAB start codon. A potential transcriptional terminator begins 4 to 6 bp downstream of the lat ORF. In the 111-bp segment between the end of the "terminator" and the pcbAB start codon, there are no Streptomyces-like or Escherichia coli-like promoter consensus sequences. However, upstream of the "terminator," that is, in the downstream portion of the lat ORF, are two regions resembling a Streptomyces consensus promoter. Promoter activity in gene fusion constructions was demonstrated in this region. A third potential promoter is upstream of the lat ORF, but only the--10 part is on the cloned DNA. The mechanism by which the cloned DNA (containing lat, the 5' part of pcbAB, and the intervening sequence) influences the expression of the downstream genes encoding ACVS and IPNS, even in strains that possess LAT activity, is an intriguing target of future investigation.
Demain
A L
AL
Department of Biology, Massachusettes Institute of Technology, Cambridge 02139.
Piret
J M
JM
Yu
H
H
Coque
J J
JJ
Liras
P
P
Martin
J F
JF
D002511:Cephalosporins / Q000096:biosynthesis*; D003001:Cloning, Molecular; D015870:Gene Expression; D005798:Genes, Bacterial; D005818:Genetic Engineering; D051306:L-Lysine 6-Transaminase; D009154:Mutation; D010088:Oxidoreductases / Q000235:genetics; D010453:Peptide Synthases / Q000235:genetics; D011401:Promoter Regions, Genetic; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism*; D000637:Transaminases / Q000235:genetics
D002511:Cephalosporins; D010088:Oxidoreductases; C038370:isopenicillin N synthetase; D000637:Transaminases; D051306:L-Lysine 6-Transaminase; D010453:Peptide Synthases; C095368:alpha-aminoadipyl-cysteinyl-valine synthetase